REQUEST A DEMO
Total
USD $0.00
Search more companies

Saneca Pharmaceuticals A. S. (Slovakia)

Main Activities: Pharmaceutical and Medicine Manufacturing | Pharmaceutical Preparation Manufacturing
Full name: Saneca Pharmaceuticals A. S. Profile Updated: April 23, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Saneca Pharmaceuticals A. S. is an enterprise based in Slovakia. Its main office is in Hlohovec. The company operates in the Pharmaceutical and Medicine Manufacturing sector. It was first established on September 19, 2012. It currently has a total number of 500 - 999 (2025) employees. From the latest financial highlights, Saneca Pharmaceuticals A. S. reported a net sales revenue increase of 15.18% in 2025. Over the same period, its total assets grew by 28.69%. In 2025, Saneca Pharmaceuticals A. S.’s net profit margin increased by 0.62%.

Headquarters
Nitrianska, 100
Hlohovec; Trnavsky; Postal Code: 92027

Contact Details: Purchase the Saneca Pharmaceuticals A. S. report to view the information.

Website: http://www.saneca.com/sk/

Basic Information
Total Employees:
Purchase the Saneca Pharmaceuticals A. S. report to view the information.
Registered Capital:
Purchase the Saneca Pharmaceuticals A. S. report to view the information.
Financial Auditors:
Purchase the Saneca Pharmaceuticals A. S. report to view the information.
Incorporation Date:
September 19, 2012
Key Executives
Purchase this report to view the information.
Chairman of the Board
Purchase this report to view the information.
Vice-chair of the Board
Purchase this report to view the information.
Vice-chair of the Board
Purchase this report to view the information.
Member of the Supervisory Board
Purchase this report to view the information.
Member of the Supervisory Board
Company Performance
Financial values in the chart are available after Saneca Pharmaceuticals A. S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
15.18%
Total Operating Revenue
15.58%
Operating Profit
15.83%
EBITDA
16.4%
Net Profit/Loss for the Period
21.97%
Total Assets
28.69%
Total Equity
17.4%
Operating Profit Margin
0.08%
Net Profit Margin
0.62%
Return on Equity (ROE)
0.82%
Debt / Equity
16.69%
Quick Ratio
0.01%
Cash Ratio
0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?